Search research articles
Contact Us
Filters
Showing results (51-60 of 120) with videos related to
Page
of 12
Sort By:
European Journal of Preventive Cardiology
|
February 5, 2020
Beyond LDL-C levels, does remnant cholesterol estimation matter?
Angela Pirillo, Giuseppe D Norata, Alberico L Catapano
Current Opinion in Clinical Nutrition and Metabolic Care
|
January 4, 2021
Recent insights into low-density lipoprotein metabolism and therapy
Angela Pirillo, Alberico L Catapano, Giuseppe D Norata
Current Atherosclerosis Reports
|
June 5, 2020
New Pharmacological Approaches to Target PCSK9
Alberico L Catapano, Angela Pirillo, Giuseppe D Norata
Current Atherosclerosis Reports
|
October 26, 2021
Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
Angela Pirillo, Alberico L Catapano, Giuseppe D Norata
Cardiovascular Research
|
May 14, 2020
Insights from ORION studies: focus on inclisiran safety
Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Cardiovascular Research
|
October 9, 2018
High-density lipoprotein cholesterol levels, cardiovascular disease risk, and cancer: a relation which does not apply to all?
Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Handbook of Experimental Pharmacology
|
December 20, 2014
HDL in infectious diseases and sepsis
Angela Pirillo, Alberico Luigi Catapano, Giuseppe Danilo Norata
Current Opinion in Lipidology
|
September 16, 2017
Strategies for the use of nonstatin therapies
Angela Pirillo, Giuseppe D Norata, Alberico L Catapano
Mediators of Inflammation
|
August 13, 2013
LOX-1, OxLDL, and atherosclerosis
Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano
Current Medical Research and Opinion
|
March 29, 2014
Postprandial lipemia as a cardiometabolic risk factor
Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano
Page
of 12
Search research articles
Search
Showing results (51-60 of 120) with videos related to
Sort By:
Page
of 12
European Journal of Preventive Cardiology
|
February 5, 2020
Beyond LDL-C levels, does remnant cholesterol estimation matter?
Angela Pirillo, Giuseppe D Norata, Alberico L Catapano
Current Opinion in Clinical Nutrition and Metabolic Care
|
January 4, 2021
Recent insights into low-density lipoprotein metabolism and therapy
Angela Pirillo, Alberico L Catapano, Giuseppe D Norata
Current Atherosclerosis Reports
|
June 5, 2020
New Pharmacological Approaches to Target PCSK9
Alberico L Catapano, Angela Pirillo, Giuseppe D Norata
Current Atherosclerosis Reports
|
October 26, 2021
Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
Angela Pirillo, Alberico L Catapano, Giuseppe D Norata
Cardiovascular Research
|
May 14, 2020
Insights from ORION studies: focus on inclisiran safety
Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Cardiovascular Research
|
October 9, 2018
High-density lipoprotein cholesterol levels, cardiovascular disease risk, and cancer: a relation which does not apply to all?
Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata
Handbook of Experimental Pharmacology
|
December 20, 2014
HDL in infectious diseases and sepsis
Angela Pirillo, Alberico Luigi Catapano, Giuseppe Danilo Norata
Current Opinion in Lipidology
|
September 16, 2017
Strategies for the use of nonstatin therapies
Angela Pirillo, Giuseppe D Norata, Alberico L Catapano
Mediators of Inflammation
|
August 13, 2013
LOX-1, OxLDL, and atherosclerosis
Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano
Current Medical Research and Opinion
|
March 29, 2014
Postprandial lipemia as a cardiometabolic risk factor
Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano
Page
of 12